Médica Sur appoints Carlos Arellano CEO
Médica Sur designa a Carlos Arellano Director General
Intel ID : 387510
|
||||
Relevant Documents
| Notice / Relevant Fact | 01 Mar 2024 | Medica_Sur_Hecho_Relevante_2024.pdf | ES |
|
| Intel ID | 387510 | |
| Value | ND | |
| Native Currency |
Mexican Peso (MXN)
Exchange Rate:  |
|
|
Financial Data - Médica Sur
(31 Dec 2017) |
Revenue: EUR 145,52m EBITDA: EUR 31,11m Exchange Rate:
|
|
| Date |
 |
|
| Country | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
30.03.08 Hospitals (Primary) 30 Healthcare / 30.03 Healthcare Facilities & Services |
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.03.08 Hospitals 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.